In the current issue:
-
The development and significance of microRNA sequence variants in carcinogenesis
Pifková Lucie et al. -
Patient delay in presenting symptoms of breast cancer in women in the Czech Republic
Černíková Kristýna Anna et al. -
Squamous cell rectal cancer in a young woman
Novisedláková Mária et al.
Reviews
Klin Onkol 2021; 34(1): 14-19.
DOI: 10.48095/ccko202114.
Keywords: breast cancer – rehabilitation – exercise – myofascial release – quality of life
Authors: Líška Dávid, Rutkowski Sebastian2021-02-17:Breast cancer rehabilitation
Keywords: breast cancer – rehabilitation – exercise – myofascial release – quality of life
Authors: Líška Dávid, Rutkowski Sebastian2021-02-17:Breast cancer rehabilitation
Klin Onkol 2021; 34(1): 20-25.
DOI: 10.48095/ccko202120.
Keywords: isomiRs – mikroRNA – sequence variants – diagnostics – biomarkers
Authors: Pifková Lucie, Veselá Petra, Slabý Ondřej2021-02-17:The development and significance of microRNA sequence variants in carcinogenesis
Keywords: isomiRs – mikroRNA – sequence variants – diagnostics – biomarkers
Authors: Pifková Lucie, Veselá Petra, Slabý Ondřej2021-02-17:The development and significance of microRNA sequence variants in carcinogenesis
Klin Onkol 2021; 34(1): 26-32.
DOI: 10.48095/ccko202126.
Keywords: ovarian cancer – DNA repair – cancer genes – next gen sequencing – mutation – genetic testing
Authors: Soukupová Jana, Lhotová Klára, Janatová Markéta, Kleiblová Petra, Vočka Michal, Foretová Lenka, Zikán Michal, Kleibl Zdeněk2021-02-17:Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer
Keywords: ovarian cancer – DNA repair – cancer genes – next gen sequencing – mutation – genetic testing
Authors: Soukupová Jana, Lhotová Klára, Janatová Markéta, Kleiblová Petra, Vočka Michal, Foretová Lenka, Zikán Michal, Kleibl Zdeněk2021-02-17:Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer
Klin Onkol 2021; 34(1): 33-39.
DOI: 10.48095/ccko202133.
Keywords: cancer – tumor biomarkers – molecular diagnostics – ddPCR
Authors: Váňová Barbora, Malicherova Bibiana, Burjanivová Tatiana, Líšková Alena, Janíková Katarína, Jašek Karin, Lasabová Zora, Tatar Miloš, Plank Lukáš2021-02-17:Droplet digital PCR as a novel diagnostic tool
Keywords: cancer – tumor biomarkers – molecular diagnostics – ddPCR
Authors: Váňová Barbora, Malicherova Bibiana, Burjanivová Tatiana, Líšková Alena, Janíková Katarína, Jašek Karin, Lasabová Zora, Tatar Miloš, Plank Lukáš2021-02-17:Droplet digital PCR as a novel diagnostic tool
Original articles
Klin Onkol 2021; 34(1): 40-48.
DOI: 10.48095/ccko202140.
Keywords: breast cancer – patient – health care – health psychology –psycho-oncology – patient delay
Authors: Černíková Kristýna Anna, Klůzová Kráčmarová Lucie, Pešoutová Markéta, Tavel Peter2021-02-17:Patient delay in presenting symptoms of breast cancer in women in the Czech Republic
Keywords: breast cancer – patient – health care – health psychology –psycho-oncology – patient delay
Authors: Černíková Kristýna Anna, Klůzová Kráčmarová Lucie, Pešoutová Markéta, Tavel Peter2021-02-17:Patient delay in presenting symptoms of breast cancer in women in the Czech Republic
Klin Onkol 2021; 34(1): 49-55.
DOI: 10.48095/ccko202149.
Keywords: triple negative breast cancer – cisplatin – neoadjuvant chemotherapy – pathological complete response – residual cancer burden
Authors: Georgy Josh Thomas, Singh Ashish, John A.O., Joel Anjana, Andrews A.G., Thumaty D.B., Rebekah G., Sigamani E., Chandramohan J., Manipadam M.T., Cherian A.J., Abraham D.T., Paul M.J., Balakrishnan. R, Backianathan S.2021-02-17:Pathological response and clinical outcomes in operable triple-negative breast cancer with cisplatin added to standard neoadjuvant chemotherapy
Keywords: triple negative breast cancer – cisplatin – neoadjuvant chemotherapy – pathological complete response – residual cancer burden
Authors: Georgy Josh Thomas, Singh Ashish, John A.O., Joel Anjana, Andrews A.G., Thumaty D.B., Rebekah G., Sigamani E., Chandramohan J., Manipadam M.T., Cherian A.J., Abraham D.T., Paul M.J., Balakrishnan. R, Backianathan S.2021-02-17:Pathological response and clinical outcomes in operable triple-negative breast cancer with cisplatin added to standard neoadjuvant chemotherapy
Case report
Klin Onkol 2021; 34(1): 56-58.
DOI: 10.48095/ccko202156.
Keywords: alpha-fetoprotein – tumor markers – testicular tumors – chemotherapy
Authors: Fedorková Lucia, Ondruš Dalibor2021-02-17:Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer
Keywords: alpha-fetoprotein – tumor markers – testicular tumors – chemotherapy
Authors: Fedorková Lucia, Ondruš Dalibor2021-02-17:Post-treatment persistent alpha-fetoprotein elevation in a patient with testicular cancer
Klin Onkol 2021; 34(1): 59-61.
DOI: 10.48095/ccko202159.
Keywords: immunotherapy – esophageal neoplasms – checkpoint inhibitors – clinical studies – PD-L1 – first-line treatment
Authors: Křížová Ĺudmila, Charvát František, Petruželka Luboš2021-02-17:Pembrolizumab as a first-line therapy in spinocellular esophageal cancer
Keywords: immunotherapy – esophageal neoplasms – checkpoint inhibitors – clinical studies – PD-L1 – first-line treatment
Authors: Křížová Ĺudmila, Charvát František, Petruželka Luboš2021-02-17:Pembrolizumab as a first-line therapy in spinocellular esophageal cancer
Klin Onkol 2021; 34(1): 62-68.
DOI: 10.48095/ccko202162.
Keywords: squamous cell – rectal cancer – radiotherapy – chemotherapy – tumor staging
Authors: Novisedláková Mária, Danihel ml. Ľudovít, Oravský Milan, Kukučka Martin, Schnorrer Milan2021-02-17:Squamous cell rectal cancer in a young woman
Keywords: squamous cell – rectal cancer – radiotherapy – chemotherapy – tumor staging
Authors: Novisedláková Mária, Danihel ml. Ľudovít, Oravský Milan, Kukučka Martin, Schnorrer Milan2021-02-17:Squamous cell rectal cancer in a young woman
Klin Onkol 2021; 34(1): 69-72.
DOI: 10.48095/ccko202169.
Keywords: prostate cancer – prostatic neoplasms – castration-resistant – reduced-dose drug use – treatment efficacy – treatment outcomes – enzalutamide
Authors: Natchagande G Gilles, Vinh-Hung Vincent2021-02-17:Four years of low dose enzalutamide for metastatic castration-resistant prostate cancer
Keywords: prostate cancer – prostatic neoplasms – castration-resistant – reduced-dose drug use – treatment efficacy – treatment outcomes – enzalutamide
Authors: Natchagande G Gilles, Vinh-Hung Vincent2021-02-17:Four years of low dose enzalutamide for metastatic castration-resistant prostate cancer
Klin Onkol 2021; 34(1): 73-77.
DOI: 10.48095/ccko202173.
Keywords: malignant melanoma – adjuvant therapy – nivolumab – ipilimumab
Authors: Žiaran Miroslav, Dvořák Petr, Hoffmann Petr, Kopecký Jindřich2021-02-17:Failure of adjuvant treatment for malignant melanoma – what next?
Keywords: malignant melanoma – adjuvant therapy – nivolumab – ipilimumab
Authors: Žiaran Miroslav, Dvořák Petr, Hoffmann Petr, Kopecký Jindřich2021-02-17:Failure of adjuvant treatment for malignant melanoma – what next?
